Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Impact of c242T Polymorphism of p22phox in the Development of Diabetic Nephropathy,in Caucasian Diabetic Type 1 Patient.

NCT01371955 is registered in ClinicalTrials.gov with University Hospital, Grenoble as lead sponsor.

NCT NCT01371955
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01371955 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Impact of c242T Polymorphism of p22phox in the Development of Diabetic Nephropathy,in Caucasian Diabetic Type 1 Patient.
Lead sponsor
University Hospital, Grenoble
Phase
Observational
Overall status
Completed
Start date
January 31, 2011
Completion date
March 31, 2013
Enrollment
162 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

diabetic nephropathy, type 1 diabetes mellitus